Work overview

Section 04 of 09

Conclusion

Complement‐Dominant Relapse of Mixed Autoimmune Hemolytic Anemia After Rituximab Response

Naru Tomigaki, Seiji Kakiuchi, Akimasa Sakamoto, Shutaro Fujioka, Isamu Harima, Hiroaki Akiyama, Ryotaro Niwa, Ikumi Takagi, Yoko Kozuki, Yoshiharu Miyata, Sou Tanaka, Hiroyuki Tsuji, and Nobuko Iwata · 2026

Contents

Section 04 of 09

  1. 01Introduction
  2. 02Case Presentation
  3. 03Discussion
  4. 04Conclusion
  5. 05Section 5
  6. 06Funding
  7. 07Ethics Statement
  8. 08Consent
  9. 09Conflicts of Interest
Text size
Work overview

Section 4 of 9

Conclusion

Naru Tomigaki, Seiji Kakiuchi, Akimasa Sakamoto, Shutaro Fujioka, Isamu Harima, Hiroaki Akiyama, Ryotaro Niwa, Ikumi Takagi, Yoko Kozuki, Yoshiharu Miyata, Sou Tanaka, Hiroyuki Tsuji, and Nobuko Iwata · about 1 minutes

Original source ↗

The longitudinal course documented a cold‐ and complement‐dominant relapse of mixed AIHA after rituximab response. Serial reassessment identified classical complement pathway activity as the predominant effector mechanism and supported the selection of C1s inhibition in this patient.